<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>4597</billNumber>
    <createDate>2019-10-02T07:12:21Z</createDate>
    <updateDate>2020-12-28T21:30:54Z</updateDate>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <introducedDate>2019-10-01</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 158 (Tuesday, October 1, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. PETERS:H.R. 4597.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8.[Page H8089]</pre>]]></constitutionalAuthorityStatementText>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2019-10-02T17:59:12Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2019-10-01T13:01:35Z</date>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hswm02</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2019-10-01T19:14:03Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2019-10-01T13:01:40Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>ACCESS for Biosimilars Act of 2020</latestTitle>
        <congress>116</congress>
        <number>3466</number>
        <type>S</type>
        <latestAction>
          <actionDate>2020-03-12</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2019-10-02</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-10-01</actionDate>
        <committees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-10-01</actionDate>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-10-01</actionDate>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-10-01</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2019-10-01</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <placeholderTextForH>2</placeholderTextForH>
        <billReferrals>2</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000608</bioguideId>
        <fullName>Rep. Peters, Scott H. [D-CA-52]</fullName>
        <firstName>Scott</firstName>
        <middleName>H.</middleName>
        <lastName>Peters</lastName>
        <party>D</party>
        <state>CA</state>
        <identifiers>
          <lisID>2113</lisID>
          <bioguideId>P000608</bioguideId>
          <gpoId />
        </identifiers>
        <district>52</district>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001308</bioguideId>
        <fullName>Rep. Brindisi, Anthony [D-NY-22]</fullName>
        <firstName>Anthony</firstName>
        <middleName />
        <lastName>Brindisi</lastName>
        <party>D</party>
        <state>NY</state>
        <identifiers>
          <lisID>2429</lisID>
          <bioguideId>B001308</bioguideId>
          <gpoId />
        </identifiers>
        <district>22</district>
        <sponsorshipDate>2019-10-01</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>K000210</bioguideId>
        <fullName>Rep. King, Peter T. [R-NY-2]</fullName>
        <firstName>PETER</firstName>
        <middleName>T.</middleName>
        <lastName>KING</lastName>
        <party>R</party>
        <state>NY</state>
        <identifiers>
          <lisID>635</lisID>
          <bioguideId>K000210</bioguideId>
          <gpoId>8064</gpoId>
        </identifiers>
        <district>2</district>
        <sponsorshipDate>2019-10-01</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2019-10-01</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2020-09-08T19:46:41Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019 or the ACCESS for Biosimilars Act of 2019</b></p> <p>This bill eliminates cost-sharing for biosimilar biological products for certain qualifying beneficiaries under Medicare medical services. Specifically, the bill eliminates cost-sharing for beneficiaries whose coverage under private health insurance, a federal program (other than Medicare), a Medicare supplemental policy, or Medicare Advantage does not already do so. The Centers for Medicare &amp; Medicaid Services must establish a process for determining a beneficiary's eligibility and notifying Medicare Advantage organizations of such determinations.</p>]]></text>
          <updateDate>2019-10-01T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <title>ACCESS for Biosimilars Act of 2019</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>ACCESS for Biosimilars Act of 2019</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend title XVIII of the Social Security Act to eliminate cost sharing for biosimilar biological products furnished under part B of the Medicare program.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType />
        <title>ACCESS for Biosimilars Act of 2019</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType />
        <title>Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2019-10-01T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr4597ih/xml/BILLS-116hr4597ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2019-10-02</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

